Status:
COMPLETED
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
Lead Sponsor:
University Medical Center Groningen
Conditions:
Carcinoma
Carcinoma, Renal Cell
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to analyse the concentration dopamine and serotonin in thrombocytes of patients with renal cell carcinoma and neuro-endocrine tumours compared to the concentrati...
Detailed Description
* To analyse the concentration catecholamines in thrombocytes of patients with clear cell renal cell carcinoma and low grade neuroendocrine tumours. * To compare these concentrations with the concentr...
Eligibility Criteria
Inclusion
- Age 18 years old or older.
- Patients with clear cell renal cell carcinoma with metastases or patients with a low-grade neuro-endocrine tumor with metastases.
- Written informed consent
Exclusion
- Use of L-dopa or SSRI.
- Patients with a second primary malignancy.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01398306
Start Date
July 1 2011
End Date
April 1 2012
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9700RB